MatsukiyoCocokaraTSE:3088 +0.72%88 Net Margin % is 4.74% as of Mar. 2026, which is 8% above its 10-year median of 4.39. GuruFocus rates TSE:3088 with a GF Score™ of 88/100 and a GF Value™ of 円2,889.47 (Modestly Undervalued). Among 668 Healthcare Providers & Services companies, MatsukiyoCocokara ranks better than 61.23% on this metric.
The historical rank and industry rank for MatsukiyoCocokara's Net Margin % or its related term are showing as below:
TSE:3088'
s Net Margin % Range Over the Past 10 Years
Min: 3.76 Med: 4.39 Max: 5.15
Current: 4.99
TSE:3088's Net Margin % is ranked better than 61.23% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 2.885
vs TSE:3088: 4.99
MatsukiyoCocokara (TSE:3088) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
MatsukiyoCocokara Net Margin % Related Terms
MatsukiyoCocokara Net Margin % Historical Data
* Premium members only.
The historical data trend for MatsukiyoCocokara's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MatsukiyoCocokara Net Margin % Competitor Comparison
For the Pharmaceutical Retailers subindustry, MatsukiyoCocokara's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MatsukiyoCocokara Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MatsukiyoCocokara's Net Margin % distribution charts can be found below:
* The bar in red indicates where MatsukiyoCocokara's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MatsukiyoCocokara (TSE:3088) has a Net Margin % of 4.74% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on MatsukiyoCocokara and its competitors. This is near median its historical median of 4.39. Over the past decade, MatsukiyoCocokara's Net Margin % has ranged from 3.76 to 5.15. According to the industry distribution chart, MatsukiyoCocokara ranks #259 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 38.8%.
Is MatsukiyoCocokara's Net Margin % too high?
MatsukiyoCocokara's current Net Margin % of 4.74% is near median its 10-year median of 4.39. Over the past 10 years, this metric has ranged from a low of 3.76 to a high of 5.15. The Healthcare Providers & Services industry median Net Margin % is 2.89. MatsukiyoCocokara's value of 4.74% is 64.3% above this industry median. Based on the distribution chart, MatsukiyoCocokara ranks #259 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, MatsukiyoCocokara has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does MatsukiyoCocokara's Net Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, MatsukiyoCocokara ranks #259 out of 668 companies for Net Margin %. This puts MatsukiyoCocokara in the upper half of its industry. The industry median Net Margin % is 2.89. MatsukiyoCocokara's value of 4.74% is 64.3% above this benchmark. Historically, MatsukiyoCocokara's own Net Margin % has ranged from 3.76 to 5.15 over the past decade. While the company's 10-year median is 4.39 vs. the industry median of 2.89, MatsukiyoCocokara has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.89, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MatsukiyoCocokara's current Net Margin % of 4.74% is 64.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on MatsukiyoCocokara and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MatsukiyoCocokara's current Net Margin % is 4.74%, which is near median its own 10-year median of 4.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MatsukiyoCocokara stock overvalued right now?
Based on GuruFocus' analysis, MatsukiyoCocokara (TSE:3088) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,889.47, compared to a current price of 円2,386.00 — trading 17.4% below its estimated fair value. The current Net Margin % is 4.74%, which is near median its 10-year median of 4.39 and 64.3% above the Healthcare Providers & Services industry median of 2.89. MatsukiyoCocokara's overall GF Score™ is 88/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For MatsukiyoCocokara (TSE:3088), the current Net Margin % is 4.74% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MatsukiyoCocokara (TSE:3088) Overvalued in 2026?
Based on GuruFocus' analysis, MatsukiyoCocokara stock appears to be undervalued.
The current stock price of 円2,386.00 is trading 17.4% below its estimated GF Value™ of 円2,889.47.
GuruFocus considers MatsukiyoCocokara to be Modestly Undervalued.
Key valuation signals for TSE:3088:
Net Margin %: 4.74% (near median its 10-year median of 4.39)
GF Value™: 円2,889.47 vs. price of 円2,386.00 (17.4% below fair value)
Industry Position: 64.3% above the Healthcare Providers & Services median (#259 of 668)
No single metric tells the full story. See the TSE:3088 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MatsukiyoCocokara & Co operates retail drugstores and insurance dispensing pharmacies in Japan. The company's main segments are the Matsumotokiyoshi Group Business, focused on stores under the Matsumotokiyoshi brand; the Cocokara Fine Group Business, centered on Cocokara Fine stores; and the Management Support Business, which procures products, oversees group operations, and manages indirect functions such as advertising and promotion. It generates the majority of its revenue from the Matsumotokiyoshi Group Business segment.
88GF Score
Get the complete analysis for TSE:3088
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3088 has been successfully added to your 
